Drug application
DOXY-LEMMON (DOXYCYCLINE HYCLATE)
Drugs@FDA ANDA 062497 · TEVA
Key facts
| Drug name | DOXY-LEMMON |
|---|---|
| Active ingredients | DOXYCYCLINE HYCLATE |
| Application type | ANDA |
| Application number | 062497 |
| Company | TEVA |
| Dosage forms | CAPSULE, ORAL |
| Strength | EQ 50MG BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Aug 23, 1984 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.